Daktari's link about Bertner's party got me interested in her book of business. I found the following interesting tidbits:
1. Bertner Advisors represents Catalent (CTLT), which IPO'd last year to the tune of $871M. They are in the business of drug delivery technologies.
2. Bertner also represents InfraredX, which is focused on a technology that can detect damage and plaque build-up in arteries (useful for preventing heart attacks). They had an IPO offering that went belly-up in February due to poor interest.
The IPO flop is disappointing, but the other two add a LOT of credibility to Bertner, IMHO. It shows that they can work with large players and in large scale scenarios. It'll be interesting to see (hopefully in the VERY near future) what they've been working on with regard to Titan.